JP2023553005A5 - - Google Patents
Info
- Publication number
- JP2023553005A5 JP2023553005A5 JP2023534050A JP2023534050A JP2023553005A5 JP 2023553005 A5 JP2023553005 A5 JP 2023553005A5 JP 2023534050 A JP2023534050 A JP 2023534050A JP 2023534050 A JP2023534050 A JP 2023534050A JP 2023553005 A5 JP2023553005 A5 JP 2023553005A5
- Authority
- JP
- Japan
- Prior art keywords
- aav
- viral vector
- composition according
- pmp22
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063120190P | 2020-12-01 | 2020-12-01 | |
| US63/120,190 | 2020-12-01 | ||
| PCT/US2021/061177 WO2022119826A1 (en) | 2020-12-01 | 2021-11-30 | Products and methods for inhibition of expression of peripheral myelin protein-22 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023553005A JP2023553005A (ja) | 2023-12-20 |
| JP2023553005A5 true JP2023553005A5 (cg-RX-API-DMAC7.html) | 2024-11-18 |
Family
ID=81853504
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023534050A Pending JP2023553005A (ja) | 2020-12-01 | 2021-11-30 | 末梢ミエリンタンパク質22の発現の阻害のための生成物及び方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240318172A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4256069A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023553005A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230134477A (cg-RX-API-DMAC7.html) |
| CN (1) | CN116917492A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021390471A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3203748A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL303308A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022119826A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118251492A (zh) * | 2021-11-18 | 2024-06-25 | 诺华股份有限公司 | 用于治疗夏科-马里-图思病的靶向pmp22的化合物 |
| AU2024265701A1 (en) | 2023-05-02 | 2025-12-04 | Research Institute At Nationwide Children's Hospital | A modular system to convert therapeutic microrna expression cassettes from polymerase iii-based to polymerase ii-based promoters |
| WO2025150052A1 (en) * | 2024-01-12 | 2025-07-17 | Potentia Ltd. | Targeted delivery of drug conjugates to schwann cells and treatment methods in schwann cell-related diseases |
| WO2025242147A1 (zh) * | 2024-05-21 | 2025-11-27 | 北京安龙生物医药有限公司 | 靶向外周髓鞘蛋白-22基因的寡核苷酸及其用途 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2847458C (en) * | 2000-12-13 | 2019-11-12 | Baylor College Of Medicine | Defects in periaxin associated with myelinopathies |
| US20040018522A1 (en) * | 2002-05-09 | 2004-01-29 | Brigham And Women's Hospital, Inc. | Identification of dysregulated genes in patients with multiple sclerosis |
| EP3495472B1 (en) * | 2011-04-21 | 2023-11-15 | Nationwide Children's Hospital, Inc. | Recombinant virus products and methods for inhibition of expression of myotilin |
| CA2842798C (en) * | 2011-07-25 | 2021-02-23 | Nationwide Children's Hospital, Inc. | Recombinant virus products and methods for inhibition of expression of dux4 |
| HK1214521A1 (zh) * | 2012-11-05 | 2016-07-29 | Genzyme Corporation | 用於治療蛋白質病的組合物和方法 |
| KR102298579B1 (ko) * | 2013-05-21 | 2021-09-07 | 유니버시티 오브 플로리다 리서치 파운데이션, 인코포레이티드 | 캡시드-변형된 raav3 벡터 조성물, 및 인간 간암의 유전자 요법에서의 용도 |
| WO2015153760A2 (en) * | 2014-04-01 | 2015-10-08 | Sangamo Biosciences, Inc. | Methods and compositions for prevention or treatment of a nervous system disorder |
| AU2016370630B2 (en) * | 2015-12-14 | 2023-04-13 | The Trustees Of The University Of Pennsylvania | Adeno-associated viral vectors useful in treatment of spinal muscular atropy |
| AU2017229778A1 (en) * | 2016-03-09 | 2018-08-16 | Ionis Pharmaceuticals, Inc. | Methods and compositions for inhibiting PMP22 expression |
| EP4650364A3 (en) * | 2016-07-06 | 2026-01-21 | Vertex Pharmaceuticals Incorporated | Materials and methods for treatment of pain related disorders |
| KR101872105B1 (ko) * | 2016-09-05 | 2018-06-27 | 사회복지법인 삼성생명공익재단 | 샤르코 마리 투스병 치료용 약학 조성물 |
| JP7277052B2 (ja) * | 2017-02-22 | 2023-05-18 | クリスパー セラピューティクス アーゲー | プロタンパク質転換酵素サブチリシン/ケキシン9型(pcsk9)関連障害の処置のための組成物および方法 |
| WO2019066490A2 (ko) * | 2017-09-28 | 2019-04-04 | 주식회사 툴젠 | 유전자 발현 조절을 위한 인위적인 게놈 조작 |
| AU2019328270B2 (en) * | 2018-08-29 | 2026-02-26 | Research Institute At Nationwide Children's Hospital | Products and methods for inhibition of expression of mutant GARS protein |
| EP3628735A1 (en) * | 2018-09-25 | 2020-04-01 | Centre National De La Recherche Scientifique | Antisense rna targeting pmp22 for the treatment of charcot-marie-tooth 1a disease |
| EP3897837A4 (en) * | 2018-12-21 | 2023-08-16 | Ionis Pharmaceuticals, Inc. | COMPOUNDS AND METHODS FOR REDUCING PMP22 EXPRESSION |
| KR20200124038A (ko) * | 2019-04-23 | 2020-11-02 | 사회복지법인 삼성생명공익재단 | 마이크로rna-381을 유효성분으로 포함하는, pmp22 과발현에 의한 말초신경병증의 예방 또는 치료용 약학적 조성물 |
| JP2022540446A (ja) * | 2019-07-10 | 2022-09-15 | ロックアネイビオ, インコーポレイテッド | Rna標的ノックダウン及び置換の組成物及び使用方法 |
| WO2021258011A1 (en) * | 2020-06-19 | 2021-12-23 | Ionis Pharmaceuticals, Inc. | Compounds and methods for modulating pmp22 |
-
2021
- 2021-11-30 WO PCT/US2021/061177 patent/WO2022119826A1/en not_active Ceased
- 2021-11-30 KR KR1020237022382A patent/KR20230134477A/ko active Pending
- 2021-11-30 CA CA3203748A patent/CA3203748A1/en active Pending
- 2021-11-30 CN CN202180092622.XA patent/CN116917492A/zh active Pending
- 2021-11-30 JP JP2023534050A patent/JP2023553005A/ja active Pending
- 2021-11-30 EP EP21901321.6A patent/EP4256069A4/en active Pending
- 2021-11-30 US US18/038,900 patent/US20240318172A1/en active Pending
- 2021-11-30 IL IL303308A patent/IL303308A/en unknown
- 2021-11-30 AU AU2021390471A patent/AU2021390471A1/en active Pending